口咽癌IMRT后下颌骨放射性骨坏死的剂量-体积相关因素:病例匹配对照研究
该研究通过1:2病例匹配对照,分析了2002至2013年接受IMRT的口咽癌患者中下颌骨放射性骨坏死(ORN)的剂量学相关因素。结果显示ORN组下颌骨平均剂量显著更高(48.1 vs 43.6Gy,p<0.0001),V35至V73各剂量体积参数均显著更高,RPA识别出V43和V58两个参数,多数ORN病例同时满足V44≥42%和V58≥25%。结论提示下颌骨V44<42%和V58<25%可作为IMRT计划可接受性的合理DVH约束。
要点
- ORN组下颌骨平均剂量显著高于对照组(48.1 vs 43.6Gy,p<0.0001)。
- 下颌骨V35至V73各剂量体积参数在ORN组均显著更高(p<0.0006)。
- 下颌骨V44<42%和V58<25%可作为IMRT计划可接受性的合理DVH约束。
核心结论
- 口咽癌IMRT患者中,下颌骨中间及高剂量区广泛DVH参数在ORN患者中均显著更高。
- 下颌骨V44<42%和V58<25%代表合理的IMRT计划可接受性DVH约束(肿瘤覆盖不受影响时)。
研究设计与样本
- 经机构审查委员会批准,识别2002至2013年接受IMRT治疗的口咽癌ORN患者,实施1:2病例对照匹配。
- 提取下颌骨剂量体积直方图(DVH),采用非参数统计比较剂量学参数,并用递归 partitioning 分析(RPA)识别ORN的DVH相关因素。
主要发现
- 共匹配68例ORN病例和131例对照,中位随访41个月,ORN中位发生时间16个月。
- ORN组下颌骨平均剂量显著更高(48.1 vs 43.6Gy,p<0.0001),但最大剂量无统计学差异。
- V35至V73各DVH区间在ORN组均显著高于对照组(p<0.0006)。
- RPA分析识别出V43和V58两个DVH参数,81%的ORN病例同时满足V44≥42%和V58≥25%。
关键数值与推荐
- 下颌骨平均剂量:ORN组48.1Gy vs 对照组43.6Gy(p<0.0001)。
- 下颌骨V35至V73各区间在ORN组均显著更高(p<0.0006)。
- RPA识别参数:V43和V58。
- 81%的ORN病例同时满足V44≥42%和V58≥25%。
- 建议约束:下颌骨V44<42%且V58<25%(肿瘤覆盖不受影响时)。
临床怎么用
- 在口咽癌IMRT计划评估中,可参考下颌骨V44<42%和V58<25%作为可接受性约束,前提是不影响肿瘤覆盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine dosimetric parameters associated with osteoradionecrosis (ORN) in oropharyngeal cancer (OPC) patients in the IMRT era. MATERIAL AND METHODS: Subsequent to institutional review board approval, we identified ORN in OPC patients treated with IMRT from 2002 to 2013. 1:2 case-control matching was implemented. Mandibular dose-volume histograms (DVH) were extracted. Dosimetric parameters were compared using non-parametric stats. Recursive partitioning analysis (RPA) was done to identify DVH correlates of ORN. RESULTS: 68 ORN cases and 131 controls were matched. Median follow-up was 41months and median time to development of ORN was 16months. Mandibular mean dose was significantly higher in the ORN cohort (48.1 vs 43.6Gy, p<0.0001). However, the maximum dose was not statistically different. DVH bins from V35 to V73 were all significantly higher in the ORN cohort compared with controls (p<0.0006). Two DVH parameters were identified in RPA analysis, V43 and V58. The majority (81%) of ORN cases were observed with both V44≥42% and V58≥25%. CONCLUSIONS: Our data demonstrate that a wide range of DVH parameters in the intermediate and high beam path were all significantly higher in ORN patients. Mandibular V44<42% and V58<25% represent reasonable DVH constraints for IMRT plan acceptability, when tumor coverage is not compromised.
引用
- Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison. Radiother Oncol. 2017. PMID: 28733053. doi:10.1016/j.radonc.2017.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。